Inhibition of Endoplasmic Reticulum Oxidoreductin 1 Modulates Neuronal Excitability and Nociceptive Sensitivity in...

Area of Science:

• Neuroscience
• Pain Research
• Cellular Biology

Background:

• Nociceptors in the peripheral nervous system become hyperexcitable in pain states.
• Dysregulated calcium buffering by endoplasmic reticulum and mitochondria contributes to nociceptor hyperexcitability.
• Endoplasmic reticulum oxidoreductin 1 (ERO1) regulates calcium transfer at endoplasmic reticulum-mitochondria contact sites (ERMCSs).

Purpose of the Study:

• To investigate if inhibiting ERO1 can reduce nociceptor hyperexcitability and pain-like behaviors.
• To determine the role of ERO1 in calcium transfer at ERMCSs and its impact on sensory neurons.
• To explore ERO1 as a potential therapeutic target for acute pain management.

Main Methods:

• Experiments were conducted using C57BL/6 mice, including behavioral tests (thermal tail flick, formalin test, post-surgical pain) and cell cultures.
• Postmortem human dorsal root ganglia (DRGs) were used for immunohistochemistry and in vitro calcium imaging.
• ERO1 inhibition was tested in vivo and in cultured mouse and human DRGs.

Main Results:

• ERO1α isoform is expressed in mouse and human DRGs.
• Peripheral administration of an ERO1 inhibitor acutely reversed nociception in mouse pain models.
• In vitro, ERO1 inhibition reduced sensory neuron excitability and mitochondrial function in both mouse and human DRGs.
• Reduced calcium transfer through ERMCSs is suggested as the mechanism for observed effects.

Conclusions:

• ERO1 inhibition dampens mitochondrial function, sensory neuron excitability, and acute pain-like behaviors in mice.
• ERO1 inhibition decreases sensory neuron excitability in post-mortem human sensory neurons.
• Targeting ERO1 represents a potential strategy for non-narcotic acute pain relief.